Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Molecular Biolology, Pathobiology, and Genetics

A Double-Strand Break Repair Defect in ATM-Deficient Cells Contributes to Radiosensitivity

Martin Kühne, Enriqueta Riballo, Nicole Rief, Kai Rothkamm, Penny A. Jeggo and Markus Löbrich
Martin Kühne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enriqueta Riballo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Rief
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Rothkamm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penny A. Jeggo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Löbrich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/0008-5472.CAN-03-2384 Published January 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The ATM protein, which is mutated in individuals with ataxia telangiectasia (AT), is central to cell cycle checkpoint responses initiated by DNA double-strand breaks (DSBs). ATM’s role in DSB repair is currently unclear as is the basis underlying the radiosensitivity of AT cells. We applied immunofluorescence detection of γ-H2AX nuclear foci and pulsed-field gel electrophoresis to quantify the repair of DSBs after X-ray doses between 0.02 and 80 Gy in confluence-arrested primary human fibroblasts from normal individuals and patients with mutations in ATM and DNA ligase IV, a core component of the nonhomologous end-joining (NHEJ) repair pathway. Cells with hypomorphic mutations in DNA ligase IV exhibit a substantial repair defect up to 24 h after treatment but continue to repair for several days and finally reach a level of unrepaired DSBs similar to that of wild-type cells. Additionally, the repair defect in NHEJ mutants is dose dependent. ATM-deficient cells, in contrast, repair the majority of DSBs with normal kinetics but fail to repair a subset of breaks, irrespective of the initial number of lesions induced. Significantly, after biologically relevant radiation doses and/or long repair times, the repair defect in AT cells is more pronounced than that of NHEJ mutants and correlates with radiosensitivity. NHEJ-defective cells analyzed for survival following delayed plating after irradiation show substantial recovery while AT cells fail to show any recovery. These data argue that the DSB repair defect underlies a significant component of the radiosensitivity of AT cells.

INTRODUCTION

DNA double-strand breaks (DSBs) represent a major threat for the maintenance of genomic integrity. These lesions can be produced by exogenous agents such as ionizing radiation and some chemicals but also arise endogenously during replication, V(D)J recombination, and meiosis (1 , 2) . If left unrepaired, they can result in permanent cell cycle arrest, induction of apoptosis or mitotic cell death (3) , and if repaired incorrectly, can lead to carcinogenesis through directly induced or delayed chromosomal rearrangements (4) . Nonhomologous DNA end-joining (NHEJ) is the major mechanism for the repair of ionizing radiation-induced DSBs in mammalian cells and also effects rearrangements during V(D)J recombination (5) . NHEJ involves the DNA end-binding heterodimer Ku70/Ku80, the catalytic subunit of the DNA-PK, the XRCC4 gene product, and DNA ligase IV (reviewed in Refs. 6 , 7 ). Recently, an additional protein, Artemis, was also shown to be involved in NHEJ during V(D)J recombination (8 , 9) . Cell lines with mutations in any of these genes are radiation sensitive and show, except for Artemis-defective cells, marked deficiencies in DSB repair after ionizing irradiation (10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20) .

Recently, hypomorphic mutations in DNA ligase IV were identified in some human patients displaying immunodeficiency and developmental delay (21) , identifying a disorder called LIG4 syndrome. Cells from one of the patients, 180BR cells, were extensively studied and found to be homozygous for a missense mutation in the LIG4 gene (22) . This mutation was shown to impair the adenylation and ligation activities of DNA ligase IV in vitro (23) . The patient did not display any abnormal clinical characteristics, including a lack of immunodeficiency, but developed leukemia at age 14 years and dramatically overresponded to radiotherapy. Because DNA ligase IV knockout mice are embryonic lethal (24) , it was suggested that the mutated protein in 180BR cells has some residual function in vivo that allows proficient V(D)J recombination and apparently normal development but is insufficient to repair the large number of DSBs introduced during radiotherapy (22 , 23) .

Ataxia telangiectasia mutated (ATM), the protein defective in the hereditary disorder ataxia telangiectasia (AT) (25) , is a serine-threonine kinase that is central to the signal transduction process initiated by DSBs (26 , 27) . AT is a neurodegenerative disease with progressive cerebellar ataxia and telangiectasia, and AT patients display clinical radiosensitivity, immunodeficiency, and show an elevated risk for cancer induction (28) . ATM is activated after ionizing irradiation (29) and phosphorylates proteins involved in cell cycle checkpoint control and DNA repair. Consequently, AT cell lines show pronounced radiosensitivity and defective activation of cell cycle checkpoints after radiation exposure (30) . This defect involves an inability to arrest at the G1-S, S, and G2-M checkpoints. Failure to effect the S-phase checkpoint results in radiation-resistant DNA synthesis, which represents a hallmark of AT cells (31 , 32) . Additionally, AT cells fail to arrest before mitosis if they are in the G2 phase at the time of irradiation (33) . The severe checkpoint deficiencies of AT cells contrast with a rather small defect in the repair of DSBs. Whereas NHEJ-deficient cells show proficient checkpoint activation but fail to repair a large fraction (40–60%) of the initially induced DSBs (5) , AT cells repair most of the induced breaks at a normal rate and have, at best, only a small elevation in the number of unrepaired DSBs (e.g., Refs. 34 , 35 ). Moreover, AT cells are usually more radiosensitive than NHEJ-deficient cells, arguing that the radiosensitivity and most of the defects in AT cells must result from checkpoint failures or other deficiencies in signal transduction and cannot be ascribed to a minor defect in the repair of DSBs.

Notwithstanding these compelling arguments, cytogenetic experiments with nondividing confluent AT cells provide indirect evidence for a more prominent DSB repair defect in AT cells. Confluent primary human AT fibroblasts held in the G1-phase during the entire repair period were analyzed by premature chromosome condensation and exhibited a level of unrepaired chromosome breaks sufficient to account for their radiosensitivity (Refs. 36 , 37 ; see Refs. 38 and 39 for further discussion). Additionally, delayed plating survival experiments, in which confluent cells are irradiated and incubated for repair before plating is performed, usually result in a large increase in radioresistance in DSB repair-proficient cells, but this is not observed in AT cells (40, 41, 42) . On the basis of this evidence, it is surprising that AT cells represent one of the most radiosensitive cell lines available and yet show a defect in DSB repair that is many fold smaller than that of the cell lines deficient in NHEJ factors. However, it is important to consider that all DSB repair measurements described thus far were performed at radiation doses well above those used for cytogenic studies and radiosensitivity measurements.

Recent studies in our laboratories have demonstrated that enumerating γ-H2AX foci (a phosphorylated histone, see Refs. 43 , 44 ) can be used to measure the repair of radiation-induced DSBs in primary human fibroblasts (45) and Chinese hamster ovary cells (46) at physiologically relevant doses. In the present study, we used γ-H2AX foci analysis in parallel to pulsed-field gel electrophoresis (PFGE) to investigate the capacity of G1-arrested NHEJ- and ATM-deficient cells for repairing DSBs induced by ionizing radiation doses between 0.02 and 80 Gy. We show that AT cells fail to repair a subset of DSBs (∼10%), irrespective of the initial number of lesions induced, whereas DNA ligase IV-deficient cells exhibit an increased repair capacity with decreasing radiation dose, are able to repair DSBs for many days after irradiation, and can reach a level of unrepaired breaks that is lower than that of AT cells. The repair measurements are supported by cell survival studies where NHEJ-deficient but not ATM-defective cells show pronounced recovery in delayed plating experiments. These data reconcile the high radiosensitivity of AT cells with their seemingly small defect in DSB repair and provide an in vivo demonstration of the residual DNA ligase IV activities in cells with hypomorphic LIG4 mutations.

MATERIALS AND METHODS

Cell Culture and Survival Experiments.

Primary human fibroblasts from the lung (MRC-5, wild-type, European Collection of Animal Cell Cultures no. 84101801) and the skin (AT1BR, deficient in ATM, European Collection of Animal Cell Cultures no. BM0020; 180BR, deficient in DNA ligase IV; Ref. 22 ) were grown in a humidified 5% CO2 atmosphere at 37°C in MEM supplemented with 10% (MRC-5) or 20% (180BR) FCS and 2 mm glutamine and antibiotics or in Nut Mix HAM’s F10 medium (AT1BR) supplemented with 15% FCS and antibiotics. For survival experiments, cells were irradiated in the exponential growth phase (Fig. 3A) ⇓ or were grown to confluence before irradiation (Fig. 3, B and C) ⇓ , plated for colony formation either immediately (Fig. 3, A and B) ⇓ or 4 days after irradiation (delayed plating experiments, Fig. 3C ⇓ ), and stained with crystal violet 3–4 weeks after plating (colonies of >30 cells were scored as survivors). The primary skin fibroblasts 48BR (wild type), 1BR (wild type), AT7BI (deficient in ATM), 411BR (deficient in DNA ligase IV), and 2BN (Fig. 5) ⇓ were cultured and analyzed for radiosensitivity as described previously (21 , 47) . All DSB repair and immunofluorescence experiments with primary human fibroblasts were performed with nondividing confluent cultures (at least 98% of the cells in G1 as determined by flow cytometry).

The human pre-B cells N114P2 (null for LIG4; Ref. 48 ) and the parental cell line, Nalm-6, were cultured in RPMI 1640 with 10% FCS, glutamine, and antibiotics. Immunofluorescence experiments were performed with plateau-phase cultures at a density of ∼2 × 106 cells/ml. At this density, the cell cycle distribution as determined by flow cytometry is as follows: ∼60% G1-; ∼20% S-; and ∼20% G2-phase cells. After radiation exposure and repair incubation, the G1-fraction slightly increases (up to ∼70% after 8 h) because cells in G2 at the time of irradiation progress into G1 during repair incubation and because cells in G1 at the time of irradiation delay entry into S (measured by two-parameter flow cytometry with bromodeoxyuridine and propidium iodide). For γ-H2AX immunofluorescence analysis, cells with a G1 DNA content were scored (they were discriminated under the microscope from G2-phase cells by the size of the nuclei). However, we cannot exclude the possibility that some cells that were scored as G1-phase cells after repair incubation were in the G2 phase at the time of irradiation. Because NHEJ-deficient cells show improved DSB repair in G2 compared with G1 (46) , this effect could lead to a slight overestimation of the repair capacity of G1-phase N114P2 cells.

Irradiation.

For PFGE measurements and survival experiments, X-irradiation was performed at 95 kV and 25 mA with a 1.3-mm aluminum filter at a dose rate of ∼5 Gy/min (Figs. 1A ⇓ , 3A ⇓ , and 4B ⇓ , left panel), and acute γ-irradiation was performed with a 60Co γ-ray source at a dose rate of 8 Gy/min (Fig. 3, B and C) ⇓ or as described previously (49) . Cells in flasks were irradiated in ice-cold PBS [137 mm NaCl, 2.7 mm KCl, 8 mm Na2HPO4, and 1.5 mm KH2PO4 (pH 7.45); for PFGE measurements] or in cell culture medium at room temperature (for survival experiments). For immunofluorescence experiments, X-irradiation was performed at 90 kV, either with a 1-mm aluminum filter (for 0.2 and 2 Gy doses, dose rate 2 Gy/min) or a 1-mm copper and a 1-mm aluminum filter (for 0.02 Gy doses, dose rate 0.06 Gy/min), and γ-irradiation (Fig. 5) ⇓ was performed as described previously (49) . Cells were irradiated on coverslips (or in vials for pre-B cells) at room temperature in cell culture medium. For low dose rate experiments (Fig. 4, C and E) ⇓ , cells in flasks were irradiated for 14 days with 60Co γ-rays inside an incubator under repair conditions (dose rate of 5.7 Gy/day). Control experiments had shown that confluent primary human fibroblasts irradiated with 80 Gy remain metabolically active without any sign of DNA degradation for many weeks if the medium is changed regularly every 7–10 days (determined by flow cytometry analysis, trypan blue exclusion, and 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyl tetrazolium bromide analysis (50) . Therefore, experiments with repair times of 14 days (Fig. 4) ⇓ were briefly interrupted after day 7 to change the medium. The dose rates of the different radiation sources were determined by chemical dosimetry and with an ionization chamber.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

DSB repair after low and high X-ray doses. A, pulsed-field gel electrophoresis analysis in MRC-5 and 180BR cells after 10, 20, 40, and 80 Gy and in AT1BR cells after 80 Gy. Error bars represent the SE from two to three independent experiments. B, γ-H2AX analysis in MRC-5, 180BR, and AT1BR cells after 2 Gy. The mean number of foci/cell for various repair times is shown. Error bars represent the SE from the analysis of 40–100 cells from one to two independent experiments.

Immunofluorescence Analysis.

MRC-5, 180BR, and AT1BR fibroblasts grown on coverslips were fixed in 2% paraformaldehyde for 15 min, washed in PBS for 3 × 10 min, and permeabilized for 5 min on ice in 0.2% Triton X-100. Pre-B cells in suspension were spotted onto glass slides (Superfrost Plus), dried briefly, and fixed with 100% methanol for 20 min at −20°C. Samples were blocked in PBS with 1% BSA or 1% FCS for 3 × 10 min at room temperature. Samples were incubated with anti-γ-H2AX antibody (R&D Systems, Minneapolis, MN) for 1 h, washed in PBS, 1% BSA (or 1% FCS) for 3 × 10 min, and incubated with Alexa Fluor 488-conjugated goat antirabbit secondary antibody (Molecular Probes, Eugene, OR) for 1 h at room temperature. Cells were washed in PBS for 4 × 10 min and mounted using Vectashield mounting medium with 4,6 diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA). Fluorescence images were captured using a Zeiss Axioplan 2 imaging epifluorescent microscope equipped with a charge-coupled device camera and ISIS software (MetaSystems, Altlussheim, Germany). Optical sections through the nuclei were captured at 0.2-μm intervals, and images were obtained by projection of the individual sections. For quantitative analysis, foci were counted by eye during the imaging process using a ×63 objective. In a single experiment, cell counting was performed until at least 40 cells and 40 foci were registered/sample. For data points that were derived from a single experiment, the error bars represent the SE from the analysis of the number of cells analyzed. For data points that were derived from more than one experiment, the error bars represent either the SE from the number of cells analyzed in the single experiments or the SE between the different experiments (whichever is highest). Immunofluorescence analysis with 48BR, 411BR, AT7BI, and 2BN fibroblasts (Fig. 5) ⇓ was performed as described earlier (51) .

DSB Repair Measurements.

After irradiation and repair incubation, cells were harvested, embedded in agarose plugs, and lysed. After washing the plugs in TE buffer [10 mm Tris-HCl, 1 mm Na2EDTA (pH 8)], PFGE was carried out with a CHEF DRIII system (Bio-Rad, Hercules, CA) in 0.8% agarose gels. The gels were run at 14°C with linearly increasing pulse times from 50 to 5000 s for 66 h at a field strength of 1.5 V/cm. Gels were stained with ethidium bromide and photographed with a charge-coupled device camera system under UV transillumination. Quantitative analysis was performed with AIDA software (raytest, Straubenhardt, Germany). The fraction of DNA entering the gel was quantified. Samples irradiated with various doses and not incubated for repair served as a calibration to determine the percentage of remaining DSBs in the repair samples from the fraction of DNA entering the gel (for details, see Ref. 52 ). A specialized PFGE assay was performed as described earlier (52 , 53) , and a 3.2-Mbp NotI restriction fragment on chromosome 21 was analyzed by DNA probe D21S1 for the determination of correct DSB rejoining events with the criterion of restriction fragment reconstitution.

RESULTS

Deficient DSB Repair in LIG4 and ATM Mutant Cells after Physiological X-Ray Doses.

In the present study, we investigated the repair of DSBs in confluent wild-type (MRC-5), DNA ligase IV-deficient (180BR), and ATM-deficient (AT1BR) primary human fibroblasts by PFGE and γ-H2AX analysis. Analysis of the time course for DSB repair by PFGE (Fig. 1A) ⇓ shows that 180BR cells have a pronounced repair defect after ionizing radiation doses between 10 and 80 Gy, consistent with previous determinations (45 , 53) . AT1BR cells, in contrast, show initially normal repair kinetics, followed by a slight but significant defect for repair times up to 24 h. The magnitude of the repair deficiency (∼10% unrepaired DSBs) is consistent with previous measurements (Ref. 54 , see Ref. 38 for a review). γ-H2AX focus formation was investigated at several time points after 2 Gy of irradiation (Fig. 2A) ⇓ . Although ionizing radiation-induced foci are visible in MRC-5 and 180BR cells 3 min after irradiation, AT1BR cells do not form foci at this time point. After 15 min incubation, the number of foci observed in AT1BR cells is similar to that of MRC-5 cells (Fig. 1B) ⇓ , suggesting that foci formation is slightly delayed but quantitatively similar between wild-type and ATM-deficient cells. This finding is in agreement with our recent work showing that H2AX phosphorylation after ionizing radiation exposure of nonreplicating cells can be carried out by ATM and DNA-PK in a redundant, overlapping manner. 3 For repair times of 4 h and longer, AT1BR cells show significantly more residual foci than MRC-5 cells, in agreement with the slight DSB repair defect observed by PFGE analysis. 180BR cells, in contrast, exhibit substantially more foci than MRC-5 and AT1BR cells for all time points up to 24 h. Significantly, for all three cell lines, the kinetics of foci disappearance after 2 Gy closely resemble the kinetics of DSB repair determined by PFGE after doses between 10 and 80 Gy. This similarity provides additional evidence that γ-H2AX foci analysis can be applied as a quantitative measure of DSB repair in NHEJ- and ATM-deficient cells.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

γ-H2AX foci formation in MRC-5, 180BR, and AT1BR cells. A, foci formation after 2 Gy of X-rays and various repair times. B, foci formation in unirradiated controls and 1 day after X-ray doses of 0.2 or 0.02 Gy. Nuclei were stained with 4,6 diamidino-2-phenylindole (blue).

Because 180BR and AT1BR cells are radiosensitive in asynchronous populations (55 , 56) , we wished to compare asynchronous cells to confluent G1-phase cells. Cell survival experiments confirm that both cell lines exhibit substantial (∼3–4 fold) radiosensitivity in asynchronous populations (Fig. 3A) ⇓ , and show that radioresistance is only marginally restored in confluent G1-phase cells plated immediately after irradiation (Fig. 3B) ⇓ . When cell survival is assessed in G1-phase cells that are plated 4 days after irradiation (delayed plating experiments), 180BR but not AT1BR cells show significant recovery compared with immediate plating conditions (Fig. 3C) ⇓ . The lack of significant recovery in delayed plating experiments with AT1BR cells is in agreement with literature data (40 , 41) and may indicate that DSBs remain unrepaired and contribute to the radiosensitivity of AT cells. The significant difference in survival of 180BR cells between delayed and immediate plating conditions, conversely, suggests that substantial DSB repair may occur during the extra time available in delayed plating experiments.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Radiosensitivity of MRC-5, 180BR, and AT1BR cells. A, survival of exponentially growing cells, plated immediately after X-irradiation. B, survival of G1-arrested cells, plated immediately after γ-irradiation. C, survival of G1-arrested cells, plated 4 days after γ-irradiation. Error bars represent the SE from three independent experiments. The 180BR and AT1BR data from B are redrawn in C in open symbols for a direct assessment of the delayed plating effect.

ATM Mutant Cells Fail to Repair a Subset of DSBs.

To investigate the capacity of 180BR and AT1BR cells to repair DSBs many days after irradiation, we have analyzed the time course for DSB repair by PFGE up to 14 days after 80 Gy X-irradiation (Fig. 4A ⇓ , Lanes 8–13). AT1BR cells show no significant DSB repair between days 1 and 14 and exhibit the same value of ∼10% unrepaired breaks during the entire incubation period. 180BR cells, in contrast, show substantial repair between days 1 and 14 and reach a level of unrepaired DSBs after day 14, which is similar to that of AT1BR cells (Fig. 4B) ⇓ . Low dose rate experiments, where the cells are continuously exposed to γ-radiation inside an incubator for 14 days at a dose rate of 5.7 Gy/day (for a total dose of 80 Gy; Fig. 4A ⇓ , Lanes 14 and 15), show proficient repair in 180BR cells but a significant fraction of unrepaired DSBs (∼5%) in AT1BR cells (Fig. 4C) ⇓ . Analysis of the time course for DSB repair between days 1 and 14 after 2 Gy of X-rays by γ-H2AX focus formation shows substantial repair up to 14 days in 180BR cells but little repair and a significant fraction of unrepaired DSBs (∼4 foci/cell, i.e., ∼6% unrepaired DSBs) after day 14 in AT1BR cells (Fig. 4D) ⇓ . Taken together, these experiments demonstrate that 180BR cells have the capacity to repair DSBs many days after irradiation, whereas AT1BR cells fail to show significant repair and exhibit a substantial fraction of unrepaired DSBs many days after irradiation. Significantly, after low dose (Fig. 4D) ⇓ or low dose rate conditions (Fig. 4C) ⇓ , the level of unrepaired DSBs in 180BR falls below that of AT1BR cells, consistent with the increased survival of 180BR cells under delayed plating conditions (Fig. 3C) ⇓ .

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Double-strand break repair in MRC-5, 180BR and AT1BR cells. A, ethidium bromide-stained gels of samples irradiated with different X-ray doses and not incubated for repair (Lanes 1–7) and of samples irradiated with 80 Gy of X-rays and incubated for several days after irradiation (Lanes 8–13). Lanes 14 and 15 show samples γ-irradiated for 14 days at low dose rate conditions and the corresponding controls. B, pulsed-field gel electrophoresis analysis (PFGE) analysis several days after 80 Gy of X-irradiation. C, PFGE analysis after low dose rate γ-irradiation. Error bars represent the SE from two to four independent experiments. D, γ-H2AX analysis after 2 Gy of X-irradiation. The mean number of foci/cell for various repair times is shown. Error bars represent the SE from the analysis of 100–200 cells from one to two independent experiments. E, analysis of DSB misrejoining by a specialized PFGE assay after low dose rate γ-irradiation. Error bars represent the SE from two independent experiments.

Using a specialized PFGE assay in which the reconstitution of a large genomic restriction fragment is quantified by Southern hybridization (57) , it is possible to identify correctly rejoined DSB ends produced by ionizing radiation. This approach in combination with conventional PFGE, which measures correctly as well as incorrectly rejoined DSB ends, allows the quantification of incorrect rejoining events, termed misrejoining (57) . We previously showed that low dose rate conditions as described above (Fig. 4C) ⇓ lead to no detectable misrejoining in wild-type MRC-5 cells but reveal a substantial misrejoining frequency in 180BR cells (53) . This finding is confirmed in the present study. Additionally, we observed that AT1BR cells show much less misrejoining than 180BR cells (Fig. 4E) ⇓ . Because elevated misrejoining frequencies are thought to result from decreased DSB repair capacity, the elevated misrejoining level in 180BR cells likely reflects the impaired but continuous DSB repair in these cells. AT1BR cells, in contrast, which show initially normal DSB repair but exhibit a significant fraction of unrepaired breaks, fail to show substantial misrejoining. Thus, we conclude that AT1BR cells have a DSB repair defect that is quantitatively and qualitatively different from the defect in 180BR cells. The latter cell line repairs the majority of DSBs with strongly compromised kinetics, which leads to an increase in the error rate, exemplified in the present study by an increase in the DSB misrejoining frequency. AT cells repair the majority of breaks with normal kinetics, leading to a low error rate, but fail to repair a subset of the induced DSBs.

We also investigated another AT line, AT7BI, and an additional DNA ligase IV-deficient cell line, 411BR, for their capacity to repair DSBs several days after 2 Gy of γ-irradiation. γ-H2AX analysis shows that AT7BI cells exhibit, compared with 411BR cells, fewer unrepaired DSBs after short repair times but more residual breaks after 2 and 3 days (Fig. 5A) ⇓ , demonstrating that the observations with 180BR and AT1BR cells represent a general feature of ATM- and DNA ligase IV-deficient cell lines. In the same experiments, we also analyzed a cell line, 2BN, with features that closely resemble those of NHEJ-deficient cells. These cells are highly radiosensitive, strongly impaired in DSB repair measured by PFGE, and show reduced V(D)J recombination. Because no deficiencies were observed in the known NHEJ factors, it was suggested that the defect of 2BN cells lies in a yet unidentified component of the NHEJ pathway (47) . Significantly, these cells show a substantial DSB repair defect by γ-H2AX analysis but, as with 180BR cells, continue to repair for several days and reach a level of unrepaired DSBs lower than that of AT7BI cells (Fig. 5A) ⇓ . This finding supports our conclusion that AT cells are defective in repairing a subset of DSBs that can be repaired by cells with defects in NHEJ. The biological importance of the ongoing repair in 411BR cells is demonstrated by the increase in cell survival if plating is performed 1 or 4 days after irradiation (Fig. 5B) ⇓ , similar to that observed with 180BR cells (Fig. 3C) ⇓ .

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

A, double-strand break repair measured by γ-H2AX analysis. Wild-type (48BR), ATM-deficient (AT7BI), DNA ligase IV-deficient (411BR), and nonhomologous end-joining-deficient cells (2BN) with a defect in a yet unidentified factor were analyzed after 2 Gy of γ-irradiation. The mean number of foci/cell for various repair times is shown. Error bars represent the SE from the analysis of 100–200 cells from one to two independent experiments. B, radiosensitivity of G1-arrested wild-type (1BR) and 411BR cells, plated either immediately (IP) or 1 or 4 days after γ-irradiation (DP). Error bars represent the SE from two to three independent experiments.

DSB Repair Deficiency in LIG4 and ATM Mutant Cells after Very Low X-Ray Doses.

We next investigated the capacity of 180BR and AT1BR cells for DSB repair after radiation doses that introduce only a few DSBs (Fig. 2B) ⇓ . The number of γ-H2AX foci initially induced by a 0.2-Gy X-ray dose is ∼7/cell, in agreement with 70 initial foci/cell after a dose of 2 Gy. After 0.02 Gy, an average of 0.7 foci/cell is introduced, i.e., the majority of the cells have one or no focus (Fig. 6A) ⇓ . The time course of repair determined by γ-H2AX analysis after 0.2 or 0.02 Gy is similar, yet not identical, to that after 2 Gy. AT1BR cells show initially normal repair but exhibit more unrepaired breaks than wild-type cells 8 and 24 h after irradiation, whereas 180BR cells show substantially more foci than wild-type cells at all time points up to 24 h (Fig. 6A) ⇓ . However, a detailed comparison of the repair kinetics of 180BR cells measured by PFGE and γ-H2AX analysis between 0.02 and 80 Gy indicates an improved repair capacity with decreasing radiation dose (compare Fig. 1 ⇓ with Fig. 6A ⇓ ). Whereas >40% of the initially induced breaks remain unrepaired 24 h after 80 Gy, this value decreases to ∼25% for the dose range between 2 and 20 Gy and even further to ∼10% for doses of 0.02 and 0.2 Gy. AT1BR cells, in contrast, show a nearly dose-independent value of ∼10% unrepaired DSBs after 24 h. Despite the improved repair capacity of 180BR cells at lower radiation doses, these cells do show a significant repair defect after 0.02 and 0.2 Gy. This observation together with the finding that 180BR cells repair DSBs for many days after irradiation (Fig. 4) ⇓ is consistent with the idea that mutated DNA ligase IV molecules in 180BR cells can perform the ligation step in NHEJ repair but do this at a reduced rate even for individually occurring breaks. At higher doses, the mutation in 180BR cells leads to a more severe repair defect, indicating that the mutated DNA ligase IV protein can handle a small but not an excessive number of DSBs.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Double-strand break repair after very low X-ray doses. A, γ-H2AX analysis in MRC-5, 180BR, and AT1BR cells irradiated with 0.2 or 0.02 Gy. Error bars represent the SE from the analysis of 100–300 (for 0.2 Gy) or 300–600 (for 0.02 Gy) cells from two independent experiments. B, γ-H2AX analysis in Nalm-6 (wild type) and N114P2 (LIG4 null) cells after 0.2 Gy. Error bars represent the SE from the analysis of 100–400 cells from two to three independent experiments. Shown are the mean numbers of radiation-induced γ-H2AX foci (i.e., the background number of foci in unirradiated controls was subtracted from the scored number of foci in the irradiated samples).

To further test the idea that the hypomorphic mutation in 180BR cells confers residual DNA ligase IV activity that leads to a DSB repair capacity, which depends on the initial number of lesions, we have investigated a human pre-B cell line, N114P2, with targeted disruptions in both LIG4 alleles (48) . Because 180BR cells show improved DSB repair at doses of ≤0.2 Gy, γ-H2AX foci formation was analyzed in N114P2 and their corresponding wild-type cells, Nalm-6, after a dose of 0.2 Gy (Fig. 6B) ⇓ . The initial number of induced DSBs as well as the time course for DSB repair is very similar between wild-type primary fibroblasts and wild-type pre-B cells, indicating that a comparison between the two different cell types may be justified. The time course of the LIG4 null pre-B cells, however, is significantly impaired in comparison with the time course of the DNA ligase IV-deficient primary fibroblasts (Fig. 6B) ⇓ . The difference is most pronounced for repair times of 8 and 24 h when N114P2 cells show, compared with 180BR cells, more than twice as many unrepaired DSBs. Because of methodological difficulties related to synchronizing suspension cells in G1 (see “Materials and Methods”), this result by itself cannot serve to demonstrate the residual DNA ligase IV activity in 180BR cells. However, in combination with the described dose dependence and the continuous repair activity of 180BR cells over many days, this experiment supports our conclusion that mutated DNA ligase IV molecules in 180BR cells have a physiological function that provides a reasonable repair capacity for a limited number of DSBs.

DISCUSSION

By using γ-H2AX foci analysis as an approach for DSB repair measurements, we conducted the first study of DSB repair in AT cells using physiologically relevant radiation doses. Our results show that AT cells held in the G1 phase of the cell cycle have a significant repair defect that is detected both by PFGE and γ-H2AX foci analysis. Although AT cells repair the majority of DSBs with kinetics similar to those of wild-type cells, a significant fraction of the induced breaks remains unrepaired. Several days after irradiation, the residual breaks in AT cells outnumber the unrepaired DSBs in NHEJ-deficient cells, which continue to repair DSBs for many days and thus finally reach a level of unrepaired DSBs similar to that of wild-type cells (Figs. 4 ⇓ and 5) ⇓ . These findings agree qualitatively with previous PFGE studies that show that AT cells exhibit a small but reproducible repair defect (34 , 35 , 58) and that NHEJ-deficient cells can repair all of the DSBs after prolonged incubation (59 , 60) . Additional evidence for prolonged DSB repair in NHEJ-deficient cells is the substantial recovery of radiosensitivity if plating is performed 4 days after irradiation (Fig. 3) ⇓ . AT cells, in contrast, show little recovery in delayed plating experiments, demonstrating that repair ceases in these cells at earlier times after irradiation. The correlation between unrepaired DSBs and survival in these experiments suggests that the striking radiosensitivity of AT cells can be attributed to a defect in repairing a subset of DSBs, as opposed to impaired cell cycle checkpoint activation.

We also detected a difference in the quality of DSB rejoining between ATM- and NHEJ-deficient cells by examining the ability of cells to reconstitute a genomic restriction fragment to its original size. In this assay, NHEJ- but not ATM-deficient cells show a high level of DSB misrejoining (Fig. 4E) ⇓ . We propose that the misrejoining occurs as a consequence of the slow rejoining. In contrast, AT cells, by not carrying out any slow rejoining, do not show elevated misrejoining. It is noteworthy that our experiments involve plateau-phase cells and therefore cannot be attributed to any impact of cell cycle checkpoints. Overall, our findings are consistent with cytogenetic studies involving premature chromosome condensation of G1-arrested primary human AT fibroblasts (36 , 37) or fluorescence in situ hybridization of mitotic cells (61 , 62) . In these studies, AT cells exhibit a substantially increased level of unrepaired chromosome breaks after irradiation compared with control cells and a smaller increase of exchange-type chromosome aberrations. The latter can be considered equivalent to the misrejoining events measured in this study. In summary, our data demonstrate that AT cells display a substantial repair defect, and we provide evidence for its link to their radiosensitivity. The slow residual rejoining in DNA ligase IV-deficient cells appears to be associated with misrejoining but elevated survival, providing evidence that misrejoining may not necessarily be a lethal event.

Radiation quantities of 0.02 Gy are frequently encountered during the use of X-rays in the clinic for diagnostic purposes. Such doses introduce approximately one DSB/cell. It is, therefore, important to investigate the factors required for the repair of an individual DSB in a cell. A repair defect can be clearly demonstrated in AT1BR and 180BR cells after 0.02 Gy (Fig. 6A) ⇓ . Thus, γ-H2AX foci analysis is a suitable approach to screen for DSB repair deficiencies using clinically relevant doses. For AT1BR cells, the fraction of unrepaired DSBs (∼10%) appears to be dose independent. For example, after the induction of 70 DSBs by a dose of 2 Gy, the average number of unrepaired DSBs/cell is 7. After 0.02 Gy, which induces on average 0.7 DSBs/cell, ∼1 of 10 cells with a DSB fails to repair the break (i.e., 10%). This suggests that the defect in AT cells cannot be attributed to a failure to detect a low number of breaks. Instead, the data suggest that ATM is required for the repair of a subset of radiation-induced breaks which arise in a dose-independent manner.

180BR cells carry a homozygous mutation (R278H) in the LIG4 gene that allowed normal development of the patient until the onset of leukemia at age 14 years but conferred marked clinical radiosensitivity (22) . On the basis of cellular and biochemical analyses of the mutant protein, it was suggested that the residual activity present in 180BR cells may be sufficient to repair the low number of DSBs introduced during V(D)J recombination but not the excessive number of DSBs after radiotherapy (23) . Here, we show that the repair capacity of 180BR cells, in contrast to AT cells, is dose dependent. After doses of 0.02 and 0.2 Gy, which introduce 0.7 and 7 DSBs/cell, respectively, the kinetics of DSB repair are faster compared with those at higher doses. As a consequence, the defect relative to AT1BR cells is dose and time dependent. For example, 180BR cells have more unrepaired DSBs than AT cells 24 h after doses of 2 Gy and higher (Fig. 1) ⇓ but exhibit a similar level of unrepaired breaks 24 h after doses of 0.02 and 0.2 Gy (Fig. 6A) ⇓ . However, notwithstanding the improved repair capacity of 180BR cells after low doses, there is still a substantial defect observed even for individually occurring breaks. This finding provides an explanation for the apparent paradox that the patient showed pronounced clinical radiosensitivity but did not display any marked immunodeficiency and additionally highlights the necessity to measure DSB repair for both mechanistic and clinical purposes at physiological radiation doses. We also examined a human pre-B LIG4−/− cell line and found a repair defect after a dose of 0.2 Gy that is greater than that of 180BR cells (Fig. 6B) ⇓ , providing additional evidence that there is residual DNA ligase IV-dependent repair capacity in 180BR cells. However, analysis of these cells at prolonged repair times is hindered by difficulties to hold them in a noncycling state.

Taken together, our experiments using γ-H2AX foci analysis in combination with PFGE demonstrate a considerable DSB repair defect in confluence-arrested G1-phase primary AT fibroblasts that lies in the inability of these cells to repair a subset of radiation-induced breaks. Our ability to use low doses for DSB repair experiments has allowed us to examine the contribution of these unrepaired breaks to survival using delayed plating experiments. We argue that the DSB repair defect underlies a substantial component of the radiosensitivity of AT cells.

Acknowledgments

We thank Jürgen Kiefer for providing the γ-ray source at the Strahlenzentrum in Giessen, Michael Lieber for providing the pre-B cell lines N114P2 and Nalm-6, and Roswitha Schepp, Lisa Woodbine, and Amanda Heywood for excellent technical assistance.

Footnotes

  • Grant support: Bundesministerium für Bildung und Forschung via the Forschungszentrum Karlsruhe Grant 02S8132 and Deutsche Zentrum für Luft und Raumfahrt e.V. Grant 50WB0017 (to M. L.), Radiation Protection Programme of the European Community FIGH-CT-1999-00012 (to M. L.), and the Primary Immunodeficiency Association (to P. A. J.).

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Requests for reprints: Markus Löbrich, Universität des Saarlandes, Fachrichtung Biophysik, D-66421 Homburg/Saar, Germany, Phone: 49-6841-1626202; Fax 49-6841-1626160; E-mail: markus.loebrich{at}uniklinik-saarland.de

  • ↵3 T. Stiff, M. O’Driscoll, N. Rief, K. Iwabuchi, M. Löbrich, and P. A. Jeggo. ATM and DNA-PK function redundantly to phosphorylate H2AX following exposure to ionizing radiation, submitted for publication.

  • Received August 1, 2003.
  • Revision received November 10, 2003.
  • Accepted November 11, 2003.
  • ©2004 American Association for Cancer Research.

References

  1. ↵
    Hoeijmakers J. H. Genome maintenance mechanisms for preventing cancer. Nature (Lond.), 411: 366-374, 2001.
    OpenUrlCrossRefPubMed
  2. ↵
    van Gent D. C., Hoeijmakers J. H., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet., 2: 196-206, 2001.
    OpenUrlCrossRefPubMed
  3. ↵
    Olive P. L. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat. Res., 150: S42-S51, 1998.
    OpenUrlCrossRefPubMed
  4. ↵
    Morgan W. F., Corcoran J., Hartmann A., Kaplan M. I., Limoli C. L., Ponnaiya B. DNA double-strand breaks, chromosomal rearrangements, and genomic instability. Mutat. Res., 404: 125-128, 1998.
    OpenUrlPubMed
  5. ↵
    Jeggo P. A. DNA breakage and repair Hall J. C. Dunlap J. C. Friedmann T. Gianelli F. eds. . Advances in Genetics, Vol. 38: 185-218, Academic Press San Diego 1998.
    OpenUrl
  6. ↵
    Karran P. DNA double strand break repair in mammalian cells. Curr. Opin. Genet. Dev., 10: 144-150, 2000.
    OpenUrlCrossRefPubMed
  7. ↵
    Smith G. C., Jackson S. P. The DNA-dependent protein kinase. Genes Dev., 13: 916-934, 1999.
    OpenUrlFREE Full Text
  8. ↵
    Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., de Villartay J. P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell, 105: 177-186, 2001.
    OpenUrlCrossRefPubMed
  9. ↵
    Moshous D., Pannetier C., de Chasseval R., Le Deist F., Cavazzana-Calvo M., Romana S., Macintyre E., Canioni D., Brousse N., Fischer A., Casanova J. L., de Villartay J. P. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J. Clin. Investig., 111: 381-387, 2003.
    OpenUrlCrossRefPubMed
  10. ↵
    Allalunis-Turner M. J., Zia P. K., Barron G. M., Mirzayans R., Day R. S. Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line. Radiat. Res., 144: 288-293, 1995.
    OpenUrlCrossRefPubMed
  11. ↵
    Biedermann K. A., Sun J. R., Giaccia A. J., Tosto L. M., Brown J. M. Scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc. Natl. Acad. Sci. USA, 88: 1394-1397, 1991.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Chang C., Biedermann K. A., Mezzina M., Brown J. M. Characterization of the DNA double strand break repair defect in scid mice. Cancer Res., 53: 1244-1248, 1993.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Dikomey E., Dahm-Daphi J., Brammer I., Martensen R., Kaina B. Correlation between cellular radiosensitivity and non-repaired double-strand breaks studied in nine mammalian cell lines. Int. J. Radiat. Biol., 73: 269-278, 1998.
    OpenUrlCrossRefPubMed
  14. ↵
    Hendrickson E. A., Qin X. Q., Bump E. A., Schatz D. G., Oettinger M., Weaver D. T. A link between double-strand break-related repair and V(D)J recombination: the scid mutation. Proc. Natl. Acad. Sci. USA, 88: 4061-4065, 1991.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Kurimasa A., Kumano S., Boubnov N. V., Story M. D., Tung C. S., Peterson S. R., Chen D. J. Requirement for the kinase activity of human DNA-dependent protein kinase catalytic subunit in DNA strand break rejoining. Mol. Cell. Biol., 19: 3877-3884, 1999.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Lees-Miller S. P., Godbout R., Chan D. W., Weinfeld M., Day R. S., Barron G. M., Allalunis-Turner J. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (Washington DC), 267: 1183-1185, 1995.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Wachsberger P. R., Li W. H., Guo M., Chen D., Cheong N., Ling C. C., Li G., Iliakis G. Rejoining of DNA double-strand breaks in Ku80-deficient mouse fibroblasts. Radiat. Res., 151: 398-407, 1999.
    OpenUrlCrossRefPubMed
  18. ↵
    Johnston P. J., MacPhail S. H., Stamato T. D., Kirchgessner C. U., Olive P. L. Higher-order chromatin structure-dependent repair of DNA double-strand breaks: involvement of the V(D)J recombination double-strand break repair pathway. Radiat. Res., 149: 455-462, 1998.
    OpenUrlPubMed
  19. ↵
    Nicolas N., Finnie N. J., Cavazzana-Calvo M., Papadopoulo D., Le Deist F., Fischer A., Jackson S. P., de Villartay J. P. Lack of detectable defect in DNA double-strand break repair and DNA-dependent protein kinase activity in radiosensitive human severe combined immunodeficiency fibroblasts. Eur. J. Immunol., 26: 1118-1122, 1996.
    OpenUrlPubMed
  20. ↵
    Wang H., Zeng Z. C., Perrault A. R., Cheng X., Qin W., Iliakis G. Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells. Nucleic Acids Res., 29: 1653-1660, 2001.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    O’Driscoll M., Cerosaletti K. M., Girard P. M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S. E., Seidel J., Gatti R. A., Varon R., Oettinger M. A., Neitzel H., Jeggo P. A., Concannon P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell., 8: 1175-1185, 2001.
    OpenUrlCrossRefPubMed
  22. ↵
    Riballo E., Critchlow S. E., Teo S. H., Doherty A. J., Priestley A., Broughton B., Kysela B., Beamish H., Plowman N., Arlett C. F., Lehmann A. R., Jackson S. P., Jeggo P. A. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol., 9: 699-702, 1999.
    OpenUrlCrossRefPubMed
  23. ↵
    Riballo E., Doherty A. J., Dai Y., Stiff T., Oettinger M. A., Jeggo P. A., Kysela B. Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J. Biol. Chem., 276: 31124-31132, 2001.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Frank K. M., Sekiguchi J. M., Seidl K. J., Swat W., Rathbun G. A., Cheng H. L., Davidson L., Kangaloo L., Alt F. W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature (Lond.), 396: 173-177, 1998.
    OpenUrlCrossRefPubMed
  25. ↵
    Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez S., et al A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Wash. DC), 268: 1700-1701, 1995.
    OpenUrlFREE Full Text
  26. ↵
    Lavin M. F., Khanna K. K. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int. J. Radiat. Biol., 75: 1201-1214, 1999.
    OpenUrlCrossRefPubMed
  27. ↵
    Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer, 3: 155-168, 2003.
    OpenUrlCrossRefPubMed
  28. ↵
    Taylor A. M., Metcalfe J. A., Thick J., Mak Y. F. Leukemia and lymphoma in ataxia telangiectasia. Blood, 87: 423-438, 1996.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Bakkenist C. J., Kastan M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature (Lond.), 421: 499-506, 2003.
    OpenUrlCrossRefPubMed
  30. ↵
    Jorgensen T. J., Shiloh Y. The ATM gene and the radiobiology of ataxia-telangiectasia. Int. J. Radiat. Biol., 69: 527-537, 1996.
    OpenUrlCrossRefPubMed
  31. ↵
    Houldsworth J., Lavin M. F. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Res., 8: 3709-3720, 1980.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Painter R. B., Young B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA, 77: 7315-7317, 1980.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Beamish H., Lavin M. F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol., 65: 175-184, 1994.
    OpenUrlCrossRefPubMed
  34. ↵
    Foray N., Arlett C. F., Malaise E. P. Dose-rate effect on induction and repair rate of radiation-induced DNA double-strand breaks in a normal and an ataxia telangiectasia human fibroblast cell line. Biochimie, 77: 900-905, 1995.
    OpenUrlPubMed
  35. ↵
    Foray N., Priestley A., Alsbeih G., Badie C., Capulas E. P., Arlett C. F., Malaise E. P. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int. J. Radiat. Biol., 72: 271-283, 1997.
    OpenUrlCrossRefPubMed
  36. ↵
    Cornforth M. N., Bedford J. S. On the nature of a defect in cells from individuals with ataxia telangiectasia. Science (Wash. DC), 227: 1589-1591, 1985.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Sasai K., Evans J. W., Kovacs M. S., Brown J. M. Prediction of human cell radiosensitivity: comparison of clonogenic assay with chromosome aberrations scored using premature chromosome condensation with fluorescence in situ hybridization. Int. J. Radiat. Oncol. Biol. Phys., 30: 1127-1132, 1994.
    OpenUrlCrossRefPubMed
  38. ↵
    Jeggo P. A., Carr A. M., Lehmann A. R. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet., 14: 312-316, 1998.
    OpenUrlCrossRefPubMed
  39. ↵
    Brown, J. M. Correspondence re: M. Stephen Meyn, Ataxia telangiectasia and cellular responses to DNA damage. Cancer Res., 55: 5991–6001, 1995. Cancer Res., 57: 2313–2315, 1997.
  40. ↵
    Weichselbaum R. R., Nove J., Little J. B. Deficient recovery from potentially lethal radiation damage in ataxia telengiectasia and xeroderma pigmentosum. Nature (Lond.), 271: 261-262, 1978.
    OpenUrlCrossRefPubMed
  41. ↵
    Arlett C. F., Priestley A. Defective recovery from potentially lethal damage in some human fibroblast cell strains. Int. J. Radiat. Biol., 43: 157-167, 1983.
    OpenUrlCrossRef
  42. ↵
    Cox R., Masson W. K., Weichselbaum R. R., Nove J., Little J. B. The repair of potentially lethal damage in x-irradiated cultures of normal and ataxia telangiectasia human fibroblasts. Int. J. Radiat. Biol., 39: 357-365, 1981.
    OpenUrlCrossRef
  43. ↵
    Rogakou E. P., Pilch D. R., Orr A. H., Ivanova V. S., Bonner W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 273: 5858-5868, 1998.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Rogakou E. P., Boon C., Redon C., Bonner W. M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol., 146: 905-916, 1999.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Rothkamm K., Löbrich M. Evidence for lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc. Natl. Acad. Sci. USA, 100: 5057-5062, 2003.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Rothkamm K., Krüger I., Thompson L. H., Löbrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell. Biol., 23: 5706-5715, 2003.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Dai Y., Hanakahi L. A., Manolis K., Riballo E., Stumm M., Harville T. O., West S. C., Oettinger M. A., Jeggo P. A. Nonhomologous end joining and V(D)J recombination require an additional factor. Proc. Natl. Acad. Sci. USA, 100: 2462-2467, 2003.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    Grawunder U., Zimmer D., Fugmann S., Schwarz K., Lieber M. R. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol. Cell., 2: 477-484, 1998.
    OpenUrlCrossRefPubMed
  49. ↵
    Kysela B. P., Lohrer H., Arrand J. E. Defects in the kinetics of the repair of DNA double-strand breaks and inhibition of DNA synthesis in the ataxia telangiectasia AT5BI-VA cell line: comparison to a corrected hybrid, atxbc. Radiat. Res., 144: 276-281, 1995.
    OpenUrlPubMed
  50. ↵
    Rief N., Löbrich M. Efficient rejoining of radiation-induced DNA double-strand breaks in centromeric DNA of human cells. J. Biol. Chem., 277: 20572-20582, 2002.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Foray N., Marot D., Gabriel A., Randrianarison V., Carr A. M., Perricaudet M., Ashworth A., Jeggo P. A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO J., 22: 2860-2871, 2003.
    OpenUrlAbstract
  52. ↵
    Rothkamm K., Löbrich M. Misrejoining of DNA double-strand breaks in primary and transformed human and rodent cells: a comparison between the HPRT region and other genomic locations. Mutat. Res., 433: 193-205, 1999.
    OpenUrlCrossRefPubMed
  53. ↵
    Rothkamm K., Kühne M., Jeggo P. A., Löbrich M. Radiation-induced genomic rearrangements formed by nonhomologous end-joining of DNA double-strand breaks. Cancer Res., 61: 3886-3893, 2001.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Löbrich M., Kühne M., Wetzel J., Rothkamm K. Joining of correct and incorrect DNA double-strand break ends in normal human and ataxia telangiectasia fibroblasts. Genes Chromosomes Cancer, 27: 59-68, 2000.
    OpenUrlCrossRefPubMed
  55. ↵
    Badie C., Goodhardt M., Waugh A., Doyen N., Foray N., Calsou P., Singleton B., Gell D., Salles B., Jeggo P., Arlett C. F., Malaise E. P. A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotype. Cancer Res., 57: 4600-4607, 1997.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    Taylor A. M., Harnden D. G., Arlett C. F., Harcourt S. A., Lehmann A. R., Stevens S., Bridges B. A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature (Lond.), 258: 427-429, 1975.
    OpenUrlCrossRefPubMed
  57. ↵
    Löbrich M., Rydberg B., Cooper P. K. Repair of X-ray-induced DNA double-strand breaks in specific NotI restriction fragments in human fibroblasts: joining of correct and incorrect ends. Proc. Natl. Acad. Sci. USA, 92: 12050-12054, 1995.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    Blöcher D., Sigut D., Hannan M. A. Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate γ-irradiation as assayed by pulsed field gel electrophoresis. Int. J. Radiat. Biol., 60: 791-802, 1991.
    OpenUrlCrossRefPubMed
  59. ↵
    DiBiase S. J., Zeng Z. C., Chen R., Hyslop T., Curran W. J., Jr., Iliakis G. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res., 60: 1245-1253, 2000.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    Nevaldine B., Longo J. A., Hahn P. J. The scid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks. Radiat. Res., 147: 535-540, 1997.
    OpenUrlPubMed
  61. ↵
    Kawata T., Ito H., George K., Wu H., Uno T., Isobe K., Cucinotta F. A. Radiation-induced chromosome aberrations in ataxia telangiectasia cells: high frequency of deletions and misrejoining detected by fluorescence in situ hybridization. Radiat. Res., 159: 597-603, 2003.
    OpenUrlCrossRefPubMed
  62. ↵
    Martin M., Genesca A., Latre L., Ribas M., Miro R., Egozcue J., Tusell L. Radiation-induced chromosome breaks in ataxia-telangiectasia cells remain open. Int. J. Radiat. Biol., 79: 203-210, 2002.
    OpenUrl
PreviousNext
Back to top
Cancer Research: 64 (2)
January 2004
Volume 64, Issue 2
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Double-Strand Break Repair Defect in ATM-Deficient Cells Contributes to Radiosensitivity
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Double-Strand Break Repair Defect in ATM-Deficient Cells Contributes to Radiosensitivity
Martin Kühne, Enriqueta Riballo, Nicole Rief, Kai Rothkamm, Penny A. Jeggo and Markus Löbrich
Cancer Res January 15 2004 (64) (2) 500-508; DOI: 10.1158/0008-5472.CAN-03-2384

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Double-Strand Break Repair Defect in ATM-Deficient Cells Contributes to Radiosensitivity
Martin Kühne, Enriqueta Riballo, Nicole Rief, Kai Rothkamm, Penny A. Jeggo and Markus Löbrich
Cancer Res January 15 2004 (64) (2) 500-508; DOI: 10.1158/0008-5472.CAN-03-2384
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Transcriptional Regulation of the Melanoma Prognostic Marker Melastatin (TRPM1) by MITF in Melanocytes and Melanoma
  • An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis
  • Expression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma
Show more Molecular Biolology, Pathobiology, and Genetics
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement